1574541-48-2

Basic information

• Product Name: 4-(tert-butyldimethylsilyloxy)-3-ethylaniline
• Synonyms: 4-(tert-butyldimethylsilyloxy)-3-ethylaniline
• CAS NO: 1574541-48-2
• Molecular Weight: 251.444
• Mol File: 1574541-48-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(tert-butyldimethylsilyloxy)-3-ethylaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(tert-butyldimethylsilyloxy)-3-ethylaniline(1574541-48-2)
• EPA Substance Registry System: 4-(tert-butyldimethylsilyloxy)-3-ethylaniline(1574541-48-2)

Safety Data

• Hazardous Substances Data: 1574541-48-2(Hazardous Substances Data)

Upstream product

• 178698-88-9 4-amino-2-ethylphenol 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 90-00-6 o-Hydroxyethylbenzene 
• 107244-56-4 2-ethyl-4-(hydroxyimino)cyclohexa-2,5-dienone 

Downstream Products

• 1574541-50-6 (±)-1-(4-(tert-butyldimethylsilyloxy)-3-ethylphenyl)-3-(4-cyclopropylphenoxy)pyrrolidin-2-one 
• 1574541-51-7 (±)-3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-hydroxyphenyl)pyrrolidin-2-one 
• 1574542-94-1 (±)-3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(2-hydroxyethoxy)phenyl)pyrrolidin-2-one 
• 1574543-04-6 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(2-hydroxyethoxy)phenyl)pyrrolidin-2-one 
• 1574543-06-8 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(2-hydroxyethoxy)phenyl)pyrrolidin-2-one 
• 1574541-52-8 (S)-2-(4-(3-(4-cyclopropylphenoxy)-2-oxopyrrolidin-1-yl)-2-ethylphenoxy)ethyl methanesulfonate 
• 1574541-53-9 (R)-2-(4-(3-(4-cyclopropylphenoxy)-2-oxopyrrolidin-1-yl)-2-ethylphenoxy)ethyl methanesulfonate 
• 1574538-15-0 (S)-3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574538-16-1 3-(4-cyclopropylphenoxy)-1-(3-ethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)pyrrolidin-2-one 
• 1574541-49-3 (±)-3-bromo-1-(4-(tert-butyldimethylsilyloxy)-3-ethylphenyl)pyrrolidin-2-one 

Relevant articles and documents

PYRROLONE OR PYRROLIDINONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are melanin concentrating hormone receptor-1 (MCHR1) antagonists which may be used as medicaments.